Latest Headlines

Latest Headlines

Abrupt departure of Novogen CEO followed upbeat Anisina presentation

The abrupt departure of Australia's Novogen Chairman Graham Kelly this week came after the jointly listed Nasdaq and Australian Stock Exchange biotech presented details of an in vivo proof of concept study for anti-tropomyosin drug candidate Anisina in July in the U.S.

HK-based Chi-Med cements Hutchison MediPharma control with eyes on oncology candidates

Hong Kong-based Hutchison China MediTech has cemented its already majority stake in Hutchison MediPharma via a share exchange deal with Japan's Mitsui & Co. in a disclosure notice with few details, but ahead of study results later this year on a promising candidate for China approval.

China's BeiGene completes $97M financing for targeted oncology candidates

China's BeiGene said it has completed financing of more than CNY450 million ($75 million) from initial angel and strategic investors as well as new investors Hillhouse Capital and CITIC PE, joined by an unnamed "blue chip U.S. public investment fund" specializing in life sciences.

SV Bio changes name to Lifecode, plans rollout of NGS cancer assay

Alongside the launch of a next generation sequencing-based oncology assay, Silicon Valley Biosystems is also rolling out a new name to reflect its mission of providing practical genetic information to patients.

Janssen rethinks drug discovery in a changing R&D environment

For William Strohl, the new head of Janssen's Biotechnology Center of Excellence, the future of drug R&D involves novel targets, "fit-for-purpose" antibodies and lots of collaborations.

Buzz: Google Ventures leading $100M round in oncology Big Data platform

When Flatiron Health emerged in 2012 with a mission to improve oncology care, its founder predicted it would either be "a great success or a horrible failure." Now the Big Data startup is reportedly on the cusp of taking a major step towards the better of these two outcomes, with Fortune writing Google's venture capital wing is leading a $100 million financing round.

GlaxoSmithKline initiates global cancer consortium

GlaxoSmithKline is launching what it calls the Oncology Clinical and Translational Consortium, a collaborative scientific research network intended to advance drug discovery that will include 6 cancer centers around the world.

Indian agency objects to Mylan vaccine plant deal

Indian officials fear the sale of the vaccine and oncology plants will limit the country's ability to supply affordable medicines to citizens.

Ex-Googlers bring Big Data analytics to oncology

When ex-Google ($GOOG) guys Nat Turner and Zach Weinberg discussed their oncology-focused startup Flatiron Health in August they were big on ambition but low on details.

Biomarker shines a light on new pathway to target neuroblastoma

A group of investigators at the prestigious Dana-Farber/Children's Hospital Cancer Center in Boston believe they may have identified the Achilles heel for a common malignant tumor found in pediatric oncology.